VP - US Regulatory Affairs

Pat Jaworski

Pat joined Alvogen in January of 2014 bringing with her 35 years of Regulatory experience and FDA interface. She provides strategic leadership and drives functional value as a subject matter expert, addressing regulatory aspects related to the submission of new ANDAs and commercialization of compliant products.

Before joining Alvogen, Pat was Vice President of US Generic Regulatory Affairs for Teva Pharmaceuticals, where she executed on functional strategy and long range objectives for Teva’s generic business operations. Pat also worked for IVAX Pharmaceuticals, where she was Director of US Generic Regulatory Affairs, Par Pharmaceuticals and Lederle Laboratories.